FL MSSP
Andrew Chang
ACO Primary Contact
202-803-7979
Location
Location

Aledade Florida Central ACO, LLC
4550 Montgomery Ave, Ste 950N
Bethesda, MD 20814
 

ACO Participants ACO Participant in Joint Venture
Cappleman Edwards and Castello MD PA N
DONALD M. COLLINS, M.D., P.A. N
FABIO ECHAVARRIA, MD, PA N
NIBHA MEDIRATTA MD PL N
North Point Physicians LLC N
Paul D Sovran MD PA N
PHYSICIANS MEDICAL GROUP, LLC N
Rivers Family Medicine PA N
Sharon Nickell-Olm M D Family Medical Center, LLC N
SOUTH LAKE MEDICAL CENTER INC N
SOUTH LAKE PRIMARY CARE P A N
Suntree Medical Associates, P.A. N

Member Last Name Member First Name Member Title/Position Member's Voting Power (Expressed as a percentage or number) Membership Type ACO PArticipant Legal Business Name and D/B/A, if applicable
Sovran Paul Voting Member 1 ACO Participant Representative Paul D Sovran MD PA
Luciani Marlo Voting Member 1 ACO Participant Representative North Point Physicians LLC
Rivers Steve Voting Member 1 ACO Participant Representative Rivers Family Medicine PA
Cappleman John Voting Member 1 ACO Participant Representative Cappleman Edwards and Castello MD PA
Nickel-Olm Sharon Voting Member 1 ACO Participant Representative Sharon Nickell-Olm M D Family Medical Center, LLC
Saladino Carl Voting Member 1 ACO Participant Representative Suntree Medical Associates, P.A.
Nasir Shazia Voting Member 1 ACO Participant Representative SOUTH LAKE MEDICAL CENTER INC
Suerio Ramon Voting Member 1 ACO Participant Representative SOUTH LAKE PRIMARY CARE P A
Hari Aashiv Voting Member 1 ACO Participant Representative PHYSICIANS MEDICAL GROUP, LLC
Medirrata Nibha Voting Member 1 ACO Participant Representative NIBHA MEDIRATTA MD PL
Echavarria Fabio Voting Member 1 ACO Participant Representative FABIO ECHAVARRIA, MD, PA
Collins Donald Voting Member 1 ACO Participant Representative DONALD M. COLLINS, M.D., P.A.
Jenkins Frank Voting Member 1 Medicare Beneficiary Representative N/A
Chang Andrew

Voting Member

   Other N/A
  • Executive Director: Mr. Andrew Chang
  • Medical Director: Dr. John Cappleman
  • Compliance Officer: Ms. Sarah Chasson
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson

Beneficiary Engagement Committee

 

  • Dr. John Cappleman
  • Cliff Jennings
     

Compliance Committee

 

  • Dr. Paul Sovran
     

Performance Improvement Committee

 

  • Dr. Paul Sovran
  • Networks of individual practices of ACO professionals

Second Agreement Period

  • Performance Year 2020, $ 2,730,568
  • Performance Year 2019: $2,018,260

First Agreement Period

  • Performance Year 2019, $2,018,260
  • Performance Year 2018, $1,620,489
  • Performance Year 2017, $3,741,517
  • Performance Year 2016, $2,263,161

Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Second Agreement Period

  • Performance Year 2020
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2019
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 100%

First Agreement Period

  • Performance Year 2019
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2018
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2017
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2016
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 100%

 

10% - Reinvest in infrastructure

30% - Invested in redesigned care processes/resources

60% - Distribution to ACO Participants

 

2020 Quality Performance Results
ACO#
Measure Name
Rate
ACO Mean
ACO-8
Risk Standardized, All Condition Readmission
15.27
15.07
ACO-38
Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions
37.61
49.50
ACO-43
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))
0.84
0.95
ACO-13
Falls: Screening for Future Fall Risk
98.46
84.97
ACO-14
Preventive Care and Screening: Influenza Immunization
91.91
76.03
ACO-17
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
100.00
81.67
ACO-18
Preventive Care and Screening: Screening for Depression and Follow-up Plan
95.31
71.46
ACO-19
Colorectal Cancer Screening
88.44
72.59
ACO-20
Breast Cancer Screening
90.19
74.05
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
84.00
83.37
ACO-40
Depression Remission at Twelve Months
22.97
13.99
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
6.37
14.70
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
90.28
72.87

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

 

Payment Rule Waivers

Waiver for Payment for Telehealth Services:

  • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
Fraud and Abuse Waivers